II. Precautions
- Used only in Anesthesia, emergency and Intensive Care
- Airway and Respiratory Control is critical after use
-
Paralytic Agents do not alter Level of Consciousness
- Must be used with sedation and analgesia
III. Indication
- Paralysis in Rapid Sequence Intubation
- Maintenance of paralysis
-
Neuromuscular Blockade drug of choice
- Except when contraindicated (see below)
IV. Contraindications
- Renal Failure (Creatinine Clearance <10 ml/min)
- Hepatic failure (due to up to 45% hepatic metabolism)
- Unstable cardiovascular status
- Shorter duration of action needed
V. Mechanism
- Non-depolarizing Neuromuscular Blocking Agent
- Structurally similar to Vecuronium
- Same steroid nucleus
- Quaternary Nitrogen at position 2 is only difference
- Significantly different effects than Vecuronium
- Primarily renal excretion (up to 70%)
- Tachycardia due to vagolytic and Sympathomimetic
- Significantly longer duration of action
VI. Dose
- Initial Dose
- Pancuronium alone: 0.06 to 0.1 mg/kg IV
- Pancuronium after Succinylcholine: 0.05 mg/kg IV
- Maintenance dosing (if needed)
- Starts 25-60 minutes after initial dose
- Please see other references for maintenance dosing
- Renal Impairment
- Do not use by intramuscular dosing
VII. Pharmacokinetics
- Onset: 2-3 minutes
- Duration: 40-60 minutes
- Primarily renal excretion (60 to 80%), but may also need dose adjustment in liver disease
VIII. References
- Miller in Katzung (1989) Pharmacology, p. 323-33
- Savarese in Miller (2000) Anesthesia, p. 412-90
- (2003) Lexicomp Drug database for Pocket PC
Images: Related links to external sites (from Bing)
Related Studies
Definition (MSH) | A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release. |
Concepts | Pharmacologic Substance (T121) , Steroid (T110) |
MSH | D010197 |
SnomedCT | 50498003, 350064000, 373738000 |
LNC | LP62277-6, MTHU036236 |
English | Pancuronium, pancuronium, Pancuronium [Chemical/Ingredient], Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl-), PANCURONIUM, Pancuronium (product), Pancuronium (substance) |
Swedish | Pankuron |
Czech | pankuronium |
Finnish | Pankuroni |
Russian | PAVULON, PANKURONII, ПАВУЛОН, ПАНКУРОНИЙ |
Japanese | パンクロニウム |
Croatian | PANKURONIJ |
Polish | Pankuronium |
Spanish | pancuronio (producto), pancuronio (sustancia), pancuronio, sustancia (sustancia), pancuronio, sustancia, pancuronio, Pancuronio |
French | Pancuronium |
German | Pancuronium |
Italian | Pancuronio |
Portuguese | Pancurônio |
Ontology: Pavulon (C0030715)
Concepts | Pharmacologic Substance (T121) , Steroid (T110) |
MSH | D010197 |
English | pavulon, Pavulon, Organon Brand of Pancuronium Bromide, Organon Teknika Brand of Pancuronium Bromide, Pancuronium Organon |